
Association of EBV and Multiple Sclerosis
Neurology® Podcast
00:00
Is There a T a One 80 Ight a T Cl Therapy That Targets E B V?
The best targets right now are with targeting the bee cells, whether it is depleting the peripheral bee cell population through toxima or ogalis. Madurna is developing an m r nd a vacine targeting e b v. A terra is enrolling for a vs two trial for a t a one 80 ight a t cl therapy that targets e b v infected tea cells. Are you optimistic? What are your thoughts about these therapies in development? And who do you think they potentially benefit? Lets start with the vacin. So iv avacin that te conferterile immunity, that is that completely preventive infection. I believe it would prevent vertally, all cases
Transcript
Play full episode